Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia

BACKGROUND: We analyzed data retrieved through a PubMed search of randomized, placebo-controlled trials of first-generation antipsychotic long-acting injectables (haloperidol decanoate, bromperidol decanoate, and fluphenazine decanoate), and a company database of paliperidone palmitate, to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopal, Srihari, Berwaerts, Joris, Nuamah, Isaac, Akhras, Kasem, Coppola, Danielle, Daly, Ella, Hough, David, Palumbo, Joseph
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083982/
https://www.ncbi.nlm.nih.gov/pubmed/21552311
http://dx.doi.org/10.2147/NDT.S17177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083982/
https://www.ncbi.nlm.nih.gov/pubmed/21552311
http://dx.doi.org/10.2147/NDT.S17177

Ejemplares similares